MEDP Q2 EPS $4.25 vs est $3.97, EBITDA $153.4Mm vs est $147.5Mm on revs $707.3Mm vs est $687.65Mm; guides FY revs $2.805-2.885B vs est $2.77

MEDP Q2 EPS $4.25 vs est $3.97, EBITDA $153.4Mm vs est $147.5Mm on revs $707.3Mm vs est $687.65Mm; guides FY revs $2.805-2.885B vs est $2.778B, EBITDA $618-642Mm vs est $616.6Mm and EPS $17.25-17.95 vs est $16.97; shares +16.45%